ReviewClinical endoscopy2020
Endoscopic Ultrasound-Guided Pancreatic Transmural Stenting and Transmural Intervention.
Review in Clinical endoscopy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 25 citations in OpenAlex.
- Article
- Transluminal forceps biopsy for a pancreaticojejunostomy stricture using a novel forceps biopsy device.Endoscopy · 2025Article
- Endoscopic ultrasound-guided pancreatic duct drainage: Progress and future outlook.World journal of gastrointestinal surgery · 2025Review
- Technical outcomes between a drill dilator and ultra-tapered mechanical dilator during EUS-guided pancreaticogastrostomy: Comparative study.Endoscopy international open · 2025Article
- Needle-free technique for guidewire manipulation during endoscopic ultrasound-guided pancreatic duct drainage.Endoscopy · 2024Article
- A novel fluoroscopic system improves visibility of devices during endoscopic ultrasound-guided pancreatic duct drainage.Endoscopy · 2024Article
- Safety and efficacy of endoscopic ultrasound-guided pancreatic duct drainage using a drill dilator: a retrospective study in Japan.Clinical endoscopy · 2024Article
- A novel spiral dilator for pancreatic duct drainage: catching two birds with one stone.Clinical endoscopy · 2024Article
- Mechanical evaluation of the dilation force of dilation devices during interventional endoscopic ultrasound.Endoscopy international open · 2024Article
- EUS-guided pancreatic duct drainage: a single-center observational study.iGIE : innovation, investigation and insights · 2024Article
- Endoscopic ultrasound-guided rendezvous manoeuvre is an alternative method of treatment for patients with complicated chronic pancreatitis, especially when endoscopic retrograde cholangiopancreatography fails.Przeglad gastroenterologiczny · 2022Article
- Endoscopic ultrasound-guided pancreaticoduodenostomy with a forward-viewing echoendoscope.VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy · 2021Article
- Endoscopic Ultrasound-Guided Pancreatic Duct Drainage: Techniques and Literature Review of Transmural Stenting.Clinical endoscopy · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Endoscopic ultrasound (EUS)-guided pancreatic access is an emergent method that can be divided into the two main techniques of EUS-guided rendezvous and pancreatic transmural stenting (PTS). While many reports have described EUS-guided procedures, the indications, technical tips, clinical effects, and safety of EUS-guided pancreatic duct drainage (EUS-PD) remain controversial. This review describes the current status of and problems associated with EUS-PD, particularly PTS. We reviewed clinical data derived from a total of 334 patients. Rates of technical and clinical success ranged from 63% to 100% and 76% to 100%, respectively. In contrast, the rate of procedure-related adverse events was high at 26.7% (89/334). The most frequent adverse events comprised abdominal pain (n=38), acute pancreatitis (n=15), bleeding (n=9), and issues associated with pancreatic juice leakage such as perigastric fluid, pancreatic fluid collection, or pancreatic juice leaks (n=8). In conclusion, indications for EUS-PTS are limited, as is the evidence of its viability, due to the scarcity of expert operators. Despite improvements made to various devices, EUS-PTS remains technically challenging. Therefore, a long-term, large-scale, multicenter study is required to establish this technique as a viable alternative drainage method.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.